UT-Southwestern cancer researchers up to 8 retractions

oncogeneA group at the University of Texas Southwestern led by Adi F. Gazdar that found evidence of inappropriate image manipulation in a number of their papers has retracted its seventh and eighth studies.

Here’s the notice for 2005’s “Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection,” in Oncogene: Continue reading UT-Southwestern cancer researchers up to 8 retractions

Obokata agrees to retract one of two STAP stem cell papers in Nature: Reports

nature 2-27-14The Kyodo News service has reported that Haruko Obokata has agreed to retract one of the two Nature papers on an easy method of making stem cells.

According to the report: Continue reading Obokata agrees to retract one of two STAP stem cell papers in Nature: Reports

Retractions 3 and 4 appear for researcher facing criminal probe; OSU co-author won’t face inquiry

dna cell biology 2Alfredo Fusco, a cancer researcher in Italy who is facing a criminal investigation for fraud, has had two more papers retracted.

Continue reading Retractions 3 and 4 appear for researcher facing criminal probe; OSU co-author won’t face inquiry

Faulty model forces rapid retraction of paper on sea ice and climate change

natgeosciLast month, researchers published a paper whose conclusions suggested that looking at Arctic sea ice in the autumn offers clues to winter temperatures in Europe.

The letter appeared — briefly, as this post will demonstrate — in Nature Geoscience. The letter, titled “High predictability of the winter Euro–Atlantic climate from cryospheric variability,” was written by Javier Garcia-Serrano and Claude Frankignoul, of the Université Pierre et Marie Curie. The journal published the letter on March 23 and retracted it on April 14.

Here’s the abstract, which can still be found online:

Continue reading Faulty model forces rapid retraction of paper on sea ice and climate change

Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship

Eriko Suzuki
Eriko Suzuki

Over the past week, there have been a number of comments on PubPeer — a site of which we’re big fans — about a 2007 paper in Oncogene.

The comments suggested that the figures in the paper had problems. Some bands seemed to be duplicated, and one of the images looked very much like that of another paper.

Then, today, first author Eriko Suzuki left this comment: Continue reading Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship

Nature corrects a correction

nature 4 9 14Last year, we reported on a Nature correction of a paper for what a McGill University committee had earlier called “intentionally contrived and falsified” figures. It turns out that the correction — like the original paper — left some Nature readers puzzled, so the journal has run a correction of the correction: Continue reading Nature corrects a correction

Lack of citation prompts correction in Nature journal

nature communicationsIt’s not unusual to hear authors bemoan the fact that a new paper doesn’t cite their work that set the stage for a scientific advance. “The journal limited me to [a seemingly abitrary number of] references,” authors sometimes shrug, with or without apology. This week, however, we found a case of that which seems to have been resolved to everyone’s satisfaction.

The authors of a September 2013 article in Nature Communications have issued a correction for the piece, which failed to cite the source of a key step in their experiment.

The article, “Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction,” came from the lab of William “Clay” Bracken, a biochemist at Weill Cornell Medical College. According to the abstract: Continue reading Lack of citation prompts correction in Nature journal

Novartis Diovan scandal claims two more papers

diabetes careA complicated story involving Novartis’s valsartan (Diovan) has led to the retraction of two more papers, one cascading from the other.

Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.

Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”

Continue reading Novartis Diovan scandal claims two more papers

“I am deeply saddened and disturbed:” Co-author of retracted Nature paper reveals how problems came to light

Ben Scheres
Ben Scheres

On Wednesday, we reported on a Nature retraction of a paper whose corresponding author had also had a Cell paper retracted, and had been found to have committed a “violation of academic integrity” by Utrecht University. Today, we present the back story of how those retractions came to be, from another co-author of both papers, Ben Scheres, of Wageningen University: Continue reading “I am deeply saddened and disturbed:” Co-author of retracted Nature paper reveals how problems came to light

Nature paper by researcher found to have violated academic integrity retracted

dhonukshe
Pankaj Dhonukshe

A 2013 paper in Nature that was among those whose first or last author had committed a “violation of academic integrity,” according to Utrecht University, has been retracted.

Here’s the notice: for “CLASP-mediated cortical microtubule organization guides PIN polarization axis,” whose corresponding author was Pankaj Dhonukshe: Continue reading Nature paper by researcher found to have violated academic integrity retracted